Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct;80(4):855-61.
doi: 10.1111/bcp.12474. Epub 2015 Jun 1.

Adverse drug reactions - examples of detection of rare events using databases

Affiliations
Review

Adverse drug reactions - examples of detection of rare events using databases

Esther W Chan et al. Br J Clin Pharmacol. 2015 Oct.

Abstract

It is recognised that randomised controlled trials are not feasible for capturing rare adverse events. There is an increasing trend towards observational research methodologies using large population-based health databases. These databases offer more scope for adequate sample sizes, allowing for comprehensive patient characterisation and assessment of the associated factors. While direct causality cannot be established and confounders cannot be ignored, databases present an opportunity to explore and quantify rare events. The use of databases for the detection of rare adverse events in the following conditions, sudden death associated with attention deficit hyperactivity disorder (ADHD) treatment, retinal detachment associated with the use of fluoroquinolones and toxic epidermal necrolysis associated with drug exposure, are discussed as examples. In general, rare adverse events tend to have immediate and important clinical implications and may be life-threatening. An understanding of the causative factors is therefore important, in addition to the research methodologies and database platforms that enable the undertaking of the research.

Keywords: adverse drug reactions; attention deficit hyperactivity disorder; database; retinal detachment; sudden death; toxic epidermal necrolysis (TEN).

PubMed Disclaimer

Similar articles

Cited by

References

    1. The Uppsala Monitoring Centre. 2013. WHO collaborating centre for international drug monitoring. Pharmacovigilance: definitions. January. Available at http://www.who-umc.org/graphics/27400.pdf (last accessed 21 July 2014)
    1. Wren C. Sudden death in children and adolescents. Heart. 2002;88:426–431. - PMC - PubMed
    1. Berger S, Kugler JD, Thomas JA, Friedberg DZ. Sudden cardiac death in children and adolescents: introduction and overview. Pediatr Clin North Am. 2004;51:1201–1209. - PubMed
    1. Gould M, Walsh B, Munfakh J, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T. Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166:992–1001. - PubMed
    1. McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment. Drug Saf. 2009;32:1089–1096. - PubMed

MeSH terms

Substances